Vertex Pharmaceuticals | Biaya Penjualan

Harga Saham
474.16
Perubahan Harian
-11.87 -2.44%
Bulanan
0.77%
Tahunan
-2.48%
Q1 Perkiraan
481.63




Biaya Penjualan Perubahan Tanggal
AbbVie USD 4.55B 757M 2025-12
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Agios Pharmaceuticals USD 1.88M 199K 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amgen USD 1.79B 128M 2025-12
Biogen USD 810.1M 205.1M 2025-09
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Insmed USD 46.16M 15.25M 2025-12
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
J&J USD 7.97B 689M 2025-12
Merck USD 3.32B 531M 2025-12
Moderna USD 452M 245M 2025-12
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Novartis USD 3.54B 217M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
PTC Therapeutics USD 16.3M 7.02M 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sangamo BioSciences 2.42M 1.11M 2024-06
Sanofi EUR 4.29B 421M 2025-12
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
United Therapeutics USD 474.7M 373.8M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12


Vertex Pharmaceuticals Biaya Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Mar 2026.